BioNexus Gene Lab Corp
BGLC6.595USD
+0.125+1.93%
Market hours （ET）Quotes delayed by 15 min
11.85MMarket Cap
LossP/E TTM
More Details of BioNexus Gene Lab Corp Company
BioNexus Gene Lab Corporation is a Malaysia-based company, which provides ribonucleic acid (RNA)-based genomic diagnostics. The Company provides a molecular lab that is focused on the application of functional genomics to enable early detection of infectious diseases and cancers. The Company operates in the biochemical industry segment through its two Malaysian subsidiaries, MRNA Scientific Malaysia and Chemrex. MRNA Scientific Malaysia owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which the Company uses in its business. The Company's non-invasive blood screening tests analyze changes in RNA to coronavirus, dengue, human immunodeficiency virus (HIV), human papillomavirus (HPV) and the risk potentiality of cancer diseases. Chemrex is a wholesaler of industrial chemicals for the manufacture of industrial, medical, appliance, aero, automotive, mechanical and electronic industries in Asean region.
Company Info
Ticker SymbolBGLC
Company nameBioNexus Gene Lab Corp
IPO dateMar 11, 2020
CEOMr. Lee Su-Leng Tan
Number of employees30
Security typeOrdinary Share
Fiscal year-endMar 11
Address10-2 Tower B, Vertical Business Suite
CityKUALA LUMPUR
Stock exchangeNASDAQ Capital Market Consolidated
CountryMalaysia
Postal code59200
Phone13072416898
Websitehttps://www.bionexusgenelab.com/
Ticker SymbolBGLC
IPO dateMar 11, 2020
CEOMr. Lee Su-Leng Tan
Company Executives
Name
Name/Position
Position
Shareholding
Change
Ms. Jook Yuen Low
Ms. Jook Yuen Low
Independent Director
Independent Director
1.26K
--
Ms. Hua Yew Chak
Ms. Hua Yew Chak
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Ms. Meng Wong Yee
Ms. Meng Wong Yee
Director
Director
--
--
Mr. Lee Su-Leng Tan
Mr. Lee Su-Leng Tan
President, Chief Executive Officer, Chief Operating Officer
President, Chief Executive Officer, Chief Operating Officer
--
--
Mr. Teong Teoh Boon
Mr. Teong Teoh Boon
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Chi Yuen (George) Leong
Mr. Chi Yuen (George) Leong
Director
Director
--
--
Mr. Ping Lin Chai
Mr. Ping Lin Chai
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Teng Fook Fong
Mr. Teng Fook Fong
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Min Fong Yeat
Mr. Min Fong Yeat
Chairman of the Board
Chairman of the Board
--
--
Mr. Chee Keong Yap
Mr. Chee Keong Yap
Independent Non-Executive Director
Independent Non-Executive Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Jook Yuen Low
Ms. Jook Yuen Low
Independent Director
Independent Director
1.26K
--
Ms. Hua Yew Chak
Ms. Hua Yew Chak
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Ms. Meng Wong Yee
Ms. Meng Wong Yee
Director
Director
--
--
Mr. Lee Su-Leng Tan
Mr. Lee Su-Leng Tan
President, Chief Executive Officer, Chief Operating Officer
President, Chief Executive Officer, Chief Operating Officer
--
--
Mr. Teong Teoh Boon
Mr. Teong Teoh Boon
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Chi Yuen (George) Leong
Mr. Chi Yuen (George) Leong
Director
Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
CEC Science and Innovation Co., Ltd
11.13%
Liew (Choong-Chin)
9.28%
Lai (Soo Kow(kenny))
6.96%
Leong (Chi Yuen (George))
6.80%
Hai (Wong Kim)
5.80%
Other
60.03%
Shareholders
Shareholders
Proportion
CEC Science and Innovation Co., Ltd
11.13%
Liew (Choong-Chin)
9.28%
Lai (Soo Kow(kenny))
6.96%
Leong (Chi Yuen (George))
6.80%
Hai (Wong Kim)
5.80%
Other
60.03%
Shareholder Types
Shareholders
Proportion
Individual Investor
39.98%
Corporation
11.13%
Hedge Fund
0.75%
Investment Advisor/Hedge Fund
0.13%
Other
48.01%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
23
934.06K
51.99%
+197.45K
2025Q1
24
939.06K
52.27%
+197.45K
2024Q4
23
9.20M
51.32%
+1.52M
2024Q3
19
7.99M
44.45%
+1.58M
2024Q2
20
11.44M
64.50%
+1.77M
2024Q1
20
11.47M
64.70%
+1.86M
2023Q4
19
9.88M
56.10%
+604.96K
2023Q3
14
9.57M
59.98%
+192.18K
2023Q2
9
9.37M
64.75%
+10.50K
2023Q1
9
9.36M
64.67%
--
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
CEC Science and Innovation Co., Ltd
200.00K
11.13%
+200.00K
--
Jan 22, 2024
Liew (Choong-Chin)
166.67K
9.28%
--
--
Feb 27, 2025
Lai (Soo Kow(kenny))
125.00K
6.96%
--
--
Feb 27, 2025
Leong (Chi Yuen (George))
122.21K
6.8%
+5.54K
+4.75%
Feb 27, 2025
Hai (Wong Kim)
104.25K
5.8%
+14.17K
+15.73%
Feb 27, 2025
Wong (Chan Chong)
103.14K
5.74%
--
--
Feb 27, 2025
Lim (Wei Foong)
36.29K
2.02%
--
--
Dec 31, 2024
Citadel Advisors LLC
9.88K
0.55%
+9.88K
--
Mar 31, 2025
Two Sigma Investments, LP
3.55K
0.2%
+3.55K
--
Mar 31, 2025
Geode Capital Management, L.L.C.
2.37K
0.13%
--
--
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
